| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |